Codes / ICD10CM / E10.3519

E10.3519 Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye

Summary

Type 1 diabetes mellitus is an autoimmune condition characterized by insufficient insulin production. When complicated by proliferative diabetic retinopathy with macular edema, abnormal blood vessel growth occurs on the retina, and fluid accumulation in the macula leads to vision impairment. This stage involves neovascularization and macular thickening, increasing the risk of central vision loss if not managed. The unspecified eye indicates the condition affects either eye without specifying which one.

Causes

Type 1 diabetes results from an autoimmune response targeting insulin-producing pancreatic cells. Proliferative diabetic retinopathy with macular edema develops due to prolonged hyperglycemia, which damages retinal blood vessels and triggers abnormal vessel growth. The underlying diabetes drives the retinal changes, including fluid leakage into the macula.

Risk Factors

  • Long duration of diabetes.
  • Poor glycemic control.
  • Hypertension.
  • Dyslipidemia.
  • Smoking.

Symptoms

  • Blurry or distorted central vision.
  • Sudden onset of floaters.
  • Vision loss or dark spots.
  • Difficulty with night vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal evaluation and imaging (e.g., optical coherence tomography or fluorescein angiography) to assess retinal neovascularization and macular edema. The unspecified eye designation is used when the affected eye is not documented.

Treatment Options

Treatment focuses on managing diabetes and addressing retinal changes. Options may include anti-VEGF injections, laser therapy, or corticosteroids to reduce macular edema and abnormal vessel growth. Glycemic control and blood pressure management are critical to slow progression.

Prognosis and Follow-Up

Prognosis depends on early intervention and consistent management. Regular eye exams are essential to monitor for progression. With proper treatment, vision loss may be prevented or minimized, but long-term follow-up is required to address potential complications.

Complications

  • Permanent vision loss or blindness.
  • Retinal detachment.
  • Glaucoma.
  • Cataracts.

Lifestyle & Prevention

  • Maintain strict glycemic control.
  • Monitor blood pressure and cholesterol.
  • Avoid smoking.
  • Attend regular eye screenings.
  • Follow a healthy diet and exercise routine.

When to Seek Professional Help

Seek immediate care if you experience sudden vision changes, increased floaters, or vision loss. Regular eye exams are recommended for those with diabetes to detect retinopathy early.

Tips for Medical Coders

Use this code when documenting Type 1 diabetes with proliferative diabetic retinopathy and macular edema affecting an unspecified eye. Ensure documentation supports the unspecified eye designation and aligns with clinical findings. Verify that the code accurately reflects the absence of eye-specific details in the medical record.

Book a walkthrough

E10.3519 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.